In addition, by targeting ERCC3 and regulating the c-MYC/miRNA cluster/target gene axis, Trip significantly enhances its ability to induce apoptosis in liver cancer cell lines both in vitro and in vivo57. Here, ERCC3 is linked to liver cancer.